The FDA has rejected vatiquinone, requesting that PTC run an additional study to prove the drug's efficacy prior to ...

The side effect is rare, according to a new study, but is also the subject of multiple lawsuits, including two filed by Long ...

The U.S. Food and Drug Administration has denied approval for PTC Therapeutics' oral medication for a rare genetic disorder ...

MBX Biosciences Inc. (NASDAQ: MBX) is one of the best IPO stocks to buy according to Wall Street analysts. On June 16, MBX ...

Alembic Pharmaceuticals receives USFDA approval to market generic acne treatment, Tretinoin Cream USP, with estimated market ...

Natco Pharma, with Lupen, launches Bosentan tablets in US after USFDA nod; bags 180-day exclusivity for treating pulmonary ...

Within the past few years, models that can predict the structure or function of proteins have been widely used for a variety ...

Federal health officials are warning sunscreen companies for violating drug regulations by selling products in unapproved ...

Vadodara: Alembic Pharmaceuticals Limited today announced that the company has received final approval from the US Food & ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

PTC Therapeutics, Inc. (NASDAQ:PTCT) saw its stock slide 5% after the U.S. Food and Drug Administration (FDA) declined to ...

The extension was needed to review newly submitted long-term clinical data for all patients in the pivotal study following an FDA information request.